RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 28, 2018

Total Value ($000): $599,105 (100.0% shares, 0.0% debt)

Holdings (32)

PTCT PTC Therapeutics Inc 11.5%
Value ($000) $68,890 Shares 4,130,115 Est. Cost $13.46 Unrealized +25.7%
RGNX Regenxbio Inc 8.7%
Value ($000) $51,910 Shares 1,561,210 Est. Cost $20.73 Unrealized +45.4%
BMY Bristol-Myers Squibb Co 8.6%
Value ($000) $51,442 Shares 839,452 Est. Cost $42.11 Unrealized +10.3%
ALNY Alnylam Pharmaceuticals Inc 7.6%
Value ($000) $45,582 Shares 358,774 Est. Cost $75.05 Unrealized +67.4%
Dicerna Pharmaceuticals Inc 7.4%
Value ($000) $44,142 Shares 5,035,662 Est. Cost $10.56 Unrealized
Achillion Pharmaceuticals Inc 6.5%
Value ($000) $39,015 Shares 13,546,902 Est. Cost $3.82 Unrealized
La Jolla Pharmaceutical Co 5.7%
Value ($000) $34,213 Shares 1,063,170 Est. Cost $25.47 Unrealized
Avexis Inc 5.2%
Value ($000) $31,125 Shares 281,242 Est. Cost $33.55 Unrealized
ABUS Arbutus Biopharma Corp 4.3%
Value ($000) $26,016 Shares 5,151,615 Est. Cost $3.27 Unrealized +79.5%
Global Blood Therapeutics Inc 4.0%
Value ($000) $23,676 Shares 601,683 Est. Cost $39.19 Unrealized
OSUR OraSure Technologies Inc 2.8%
Value ($000) $16,568 Shares 878,452 Est. Cost $13.47 Unrealized +34.5%
BCRX BioCryst Pharmaceuticals Inc 2.8%
Value ($000) $16,560 Shares 3,372,674 Est. Cost $7.22 Unrealized -32.9%
Corium International Inc 2.7%
Value ($000) $16,334 Shares 1,699,653 Est. Cost $7.97 Unrealized
Agenus Inc 2.4%
Value ($000) $14,115 Shares 4,329,816 Est. Cost $7.48 Unrealized
EW Edwards Lifesciences Corp 2.3%
Value ($000) $13,863 Shares 123,000 Est. Cost $36.70 Unrealized 0.0%
VRAYQ Viewray Inc 2.1%
Value ($000) $12,484 Shares 1,348,210 Est. Cost $6.34 Unrealized +26.3%
Myokardia Inc 1.8%
Value ($000) $10,848 Shares 257,663 Est. Cost $42.84 Unrealized
MASI Masimo Corp 1.7%
Value ($000) $10,252 Shares 120,900 Est. Cost $66.53 Unrealized +30.4%
Atara Biotherapeutics Inc 1.7%
Value ($000) $10,066 Shares 556,118 Est. Cost $17.06 Unrealized
Proteostasis Therapeutics Inc 1.5%
Value ($000) $8,745 Shares 1,500,000 Est. Cost $5.83 Unrealized
Viveve Medical Inc 1.4%
Value ($000) $8,315 Shares 1,672,998 Est. Cost $4.99 Unrealized
QURE Uniqure NV 1.3%
Value ($000) $7,905 Shares 403,524 Est. Cost $15.23 Unrealized 0.0%
VCEL Vericel Corp 1.2%
Value ($000) $7,111 Shares 1,304,801 Est. Cost $4.61 Unrealized 0.0%
Odonate Therapeutics Inc 1.1%
Value ($000) $6,768 Shares 297,555 Est. Cost $22.75 Unrealized
TCMD Tactile Systems Technology Inc 1.0%
Value ($000) $6,096 Shares 210,366 Est. Cost $17.26 Unrealized +68.1%
Oxford Immunotec Global PLC 0.9%
Value ($000) $5,250 Shares 375,792 Est. Cost $15.20 Unrealized
Bovie Medical Corp 0.8%
Value ($000) $4,557 Shares 1,752,611 Est. Cost $3.11 Unrealized
Zynerba Pharmaceuticals Inc 0.4%
Value ($000) $2,540 Shares 202,859 Est. Cost $8.42 Unrealized
Five Prime Therapeutics Inc 0.4%
Value ($000) $2,200 Shares 100,377 Est. Cost $21.92 Unrealized
ARGX argenx NV 0.3%
Value ($000) $1,595 Shares 25,260 Est. Cost $21.81 Unrealized
Revance Therapeutics Inc 0.1%
Value ($000) $824 Shares 23,038 Est. Cost $35.77 Unrealized
SENSUS HEATLHCARE INC 0.0%
Value ($000) $98 Shares 151,400 Est. Cost $0.50 Unrealized